Patient leaflet - Midodrine Hydrochloride 2.5 mg tablets
1. What Midodrine Hydrochloride Tablets are and what are they used for
The name of your medicine is Midodrine Hydrochloride Tablets. They contain the medicine midodrine hydrochloride. This belongs to a group of medicines called adrenergic and dopaminergic agents. Midodrine hydrochloride is a medicine that raises your blood pressure and is used to treat certain severe forms of low blood pressure in adults when other treatments have not worked.
2. What you need to know before you take Midodrine Hydrochloride Tablets
Do not take Midodrine Hydrochloride Tablets if you:
- are allergic to midodrine hydrochloride or any of the other ingredients of this medicine (listed in section 6)
- have high blood pressure
- have a slow pulse
- have difficulty urinating
- have certain forms of cardiovascular disease
- have elevated pressure in the eye (glaucoma) or poor vision as a result of diabetes
- have an overactive thyroid gland
- have hormonal disorders caused by a tumour in the adrenal medulla (pheochromocytoma),
- have severe kidney disease
- have an enlarged prostate.
Warnings and precautions
Talk to your doctor or pharmacist before taking this medicine if you have been told you have high blood pressure when you lie down. If this applies to you then:
- regular monitoring of your blood pressure when you are lying down and when you are standing up will be required as there may be a risk of your blood pressure rising when you lie down, for example, at night. If your blood pressure does go up when you lie down and reducing the dose does not correct this problem, then treatment with this medicine must be stopped
- it is important that you do not take this medicine late in the evening. Take your last daily dose at least 4 hours before you go to bed. By keeping your head elevated at night the potential risk of your blood pressure rising when you lie down is reduced.
Also talk to your doctor if you:
have a serious disorder of the nervous system (autonomous nervous system disorder), since taking this medicine may lead to a further drop in blood pressure when you stand up. If this occurs, further treatment with this medicine should be stopped
- suffer from problems with your blood circulation, especially if you have symptoms such as pain or cramps in the stomach after eating, or pain or cramps in the legs while walking
- suffer from a disease of the prostate, as you may find passing urine is difficult when taking this medicine.
It is important that you immediately report symptoms related to high blood pressure, such as chest pain, palpitations, shortness of breath, elevated heart rate, headache and blurred vision. Your doctor will then decide whether to adjust the dosage or discontinue your treatment with Midodrine Hydrochloride tablets.
If any of the warnings apply to you, or have in the past, talk to your doctor.
Children and adolescents
Do not give this medicine to children and adolescents under the age of 18 because the safety and efficacy of Midodrine Hydrochloride Tablets in this age group have not been established.
Other medicines and Midodrine
Hydrochloride Tablets
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular tell your doctor or pharmacist if you are taking any of the following:
- concomitant use with these medicines may cause a large increase in blood pressure
- reserpine and guanethidine (medicines used to reduce high blood pressure)
- antihistamines (used to treat allergies)
- hormones for the thyroid (used when the thyroid is not working properly)
- tricyclic antidepressants and MAO-inhibitors (both used to treat depression)
- other vasoconstrictors (medicines that narrow blood vessels), or sympathomimetic agents (medicines that have a stimulating effect on certain parts of the nervous system)
- prazosin and phentolamine (medicines used to treat heart disease) because the effect of this medicine is blocked by these drugs
- digitalis preparations (medicines used to treat heart disease) because concomitant use with this medicine may lead to cardiac dysfunction
- corticosteroids, such as fludrocortisone acetate (an anti-inflammatory medicine) because these medicine may increase its effect
medicines which directly or indirectly reduce your heart rate because if this medicine is combined with these medicines, it is advisable that your doctor closely monitors you. Midodrine Hydrochloride Tablets with food
Midodrine Hydrochloride Tablets may be taken with food.
Pregnancy and breast-feeding
Using this medicine while pregnant is not recommended, or if you are a woman of childbearing potential not using contraception. Tell your doctor if you are pregnant, or want to be, while you are being treated with this medicine.
Do not use this medicine while breast-feeding. Driving and using machines
This medicine should not affect your ability to drive or use machines. However, you must be careful if dizziness or light-headedness occurs after taking this medicine.
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
Midodrine Hydrochloride 2.5 mg, 5 mg and 10 mg Tablets
Midodrine Hydrochloride 5 mg and 10 mg Tablets contains Sunset Yellow FCF (E110)
Sunset yellow can cause allergic reactions.
3. How to take Midodrine Hydrochloride Tablets
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Swallow tablets with a drink of water.
How much you should take
Your doctor will decide your dose and tell you how long you should take this medicine. The treatment is usually long-term.
The recommended starting dose is normally one tablet of 2.5 mg, three times a day. This dose can be increased weekly up to four 2.5 mg tablets, or two 5 mg tablets, or one 10 mg tablet three times daily, which is the usual maintenance dose of 30 mg per day.
The recommended total daily dose should be spread evenly into three doses per day. Timing of the evening dose
Avoid taking this medicine in the late evening. The last dose should be taken at least 4 hours before your bedtime. Elevating your head at night reduces the potential risk of high blood pressure when you lie down.
More information can be found in the section “Warnings and precautions” of this leaflet. If you feel that the effect of this medicine is too strong, or too weak, talk to your doctor or pharmacist.
If you take more Midodrine Hydrochloride Tablets than you should
If you have used too much of this medicine please contact your doctor or pharmacist immediately.
Taking too much of this medicine can cause:
- high blood pressure (hypertension) e.g. palpitations, shortness of breath, chest pain, headache and blurred vision
- slow heart rhythm (bradycardia)
- difficulty urinating
- goosebumps
- feeling of coldness.
If you forget to take Midodrine Hydrochloride Tablets
If you forget to take a dose, take your next dose as usual and then keep taking your medicine as your doctor has told you. Do not take a double dose to make up for a forgotten dose, because this will increase the risk of high blood pressure when you lie down.
If you stop taking Midodrine Hydrochloride Tablets
Do not stop taking these tablets without talking to your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. Very common (may affect more than 1 in 10 people)
- goosebumps, itching of the scalp and pain when urinating.
Common (may affect more than 1 in 100 but less than 1 in 10 people)
- tingling and itching, increased blood pressure when lying down, headache, nausea (feeling sick), heartburn, inflammation of the lining inside the mouth, flushing, rash, chills, difficulty urinating.
Uncommon (may affect more than 1 in 1,000 but less than 1 in 100 people)
- sleep disturbances including difficulty sleeping, restlessness, agitation and irritability, slowed heart rate, urge to urinate.
Rare (may affect more than 1 in 10,000 but less than 1 in 1,000 people)
palpitations, rapid heartbeat, abnormal liver function including an increase in the number of liver enzymes.
Not known (frequency cannot be estimated from the available data)
- abdominal pain, being sick (vomiting), diarrhoea, anxiety, feelings of confusion. Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Midodrine Hydrochloride Tablets
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton or blister. The expiry date refers to the last day of that month. Do not store above 25°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Midodrine Hydrochloride Tablets contain
The active substance(s) is midodrine hydrochloride and each tablet contains either 2.5 mg or 5 mg or 10 mg midodrine hydrochloride.
The other ingredients are microcrystalline cellulose, maize starch, magnesium stearate, talc and silica colloidal anhydrous.
Midorine Hydrochloride 5 mg and 10 mg tablets also contain Sunset Yellow FCF(E110). What Midodrine Hydrochloride Tablets looks like and contents of the pack
The 2.5 mg tablets are white, round tablets with M2 debossed on one side and score line on the other side.
The 5 mg tablets are orange, round tablets with M5 debossed on one side and score line on the other side.
The 10 mg tablets are orange, round tablets with MX debossed on one side and plain on the other side.
The tablets are supplied in blisters and are available in packs of 7, 10, 14, 20, 28, 30, 56, 60, 84, 90, 100, 112 or 120 tablets.
Not all packs may be marketed.
Marketing Authorisation Holder
Morningside Healthcare Limited
Unit C, Harcourt Way
Leicester
LE19 1WP, UK
Manufacturer
Morningside Pharmaceuticals Ltd
5 Pavilion Way
Loughborough
LE11 5GW, UK
Morningside Pharmaceuticals Limited & Aspire Pharma Limited
Second Floor, Boss Court
7 Barton Close, Grove Park
Leicester, LE19 1SJ, UK
Aspire Pharma Limited
Unit 4, Rotherbrook Court
Bedford Road
Petersfield
GU32 3QG, UK
This leaflet was last revised in July 2025.
MPL19134 - P1.4
PL/PA no: PL 20117/0275-276 & PL 20117/0427 Type: Leaflet
Date of revision: 05.08.25
Colours: As swatches
Font(s): Nimbus Sans L
A/W software: Indesign CC